MDxHealth SA risk profile
39 Normal where most of the sector sits
Measured 1 September 2026 from MDXH's filed statements. Recomputed nightly.
39 (Normal), driven by Leverage and coverage at 94, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 80 | Acute | Volatile | One-year price volatility — 113.5% |
| Operating pressure | 2 | Contained | Stable | Costs outgrowing revenue — -11.8 percentage points |
| Cash conversion | 87 | Acute | Easing | Capital spending against operating cash — -0.53x |
| Leverage and coverage | 94 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 20 | Normal | Stable | R&D-intensity gap against peers — -53.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.